Search Results 731-740 of 18605 for Relapse

  1. Clinical trials - Oncology (Medical)

    KTX-100 MMSET Catalytic Inhibitor that Suppresses H3K36me2 in Patients with Relapsed and Refractory Multiple Myeloma. Rochester, Minn., Jacksonville, Fla ...

  2. A Study to Evaluate Tazemetostat Combined with Lenalidomide Plus Rituximab in Subjects With Relapsed/Refractory Follicular Lymphoma - Mayo Clinic

    The purpose of this study is to evaluate the effectiveness and safety of tazemetostat in combination with R2 in subjects with Relapsed/Refractory Follicular ...

  3. A Study to Determine Recommended Dose, Regimen and Evaluate the Safety and Preliminary Effectiveness of CC-92480 in Combination With Standard Treatments in Subjects with Relapsed or Refractory Multiple Myeloma (RRMM) and Newly Diagnosed Multiple Myeloma (NDMM) - Mayo Clinic

    ... Relapsed or Refractory Multiple Myeloma (RRMM) and Newly Diagnosed Multiple Myeloma (NDMM). Print details. Share; Facebook · Twitter. Overview; Participation ...

  4. A Study to Evaluate the Safety And Effectiveness of Using Eculizumab in Patients with Relapsing Neuromyelitis Optica - Mayo Clinic

    ... relapse study design. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health ...

  5. Daratumumab and hyaluronidase-fihj (subcutaneous route) - Side effects & uses - Mayo Clinic

    Daratumumab and hyaluronidase-fihj combination injection is also used together with carfilzomib and dexamethasone to treat relapsed (cancer that has come ...

  6. Cutaneous B-Cell Lymphoma Clinical Trials - Mayo Clinic Research

    ... relapsed or refractory (R/R) lymphoma. Subjects must have received at least ... This phase II trial studies how well giving ruxolitinib phosphate (oral JAK ...

  7. Abatacept for the Treatment of Relapsing, Non-Severe, Granulomatosis With Polyangiitis (Wegener's) - Mayo Clinic

    ... relapse or disease flare. Participants who experience a non-severe disease relapse, non-severe disease worsening, or who have not achieved remission by ...

  8. Clinical trials - Oncology (Medical)

    ... Relapsed Favorable Histology Wilms Tumors A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT. Rochester, Minn. The ...

  9. Medical Research & Education - Mayo Clinic News Network

    Root Cause of Multiple Myeloma Relapse Revealed. Dana Sparks. September 18, 2013. Cancer. Mayo Clinic Receives $8.8 Million Federal Grant for Metabolomics ...

  10. Mayo Clinic's high-tech pursuit of precision alcohol addiction treatment

    ... relapse and how long they can stay in recovery," says Ming-Fen Ho, Ph.D., a lead author and a stem cell biologist in the Department of Psychiatry and ...